Get startedLog in
    Picture of Yichang Hec Changjiang Pharmaceutical Co logo

    1558 — Yichang Hec Changjiang Pharmaceutical Co News Story

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareSpeculativeMid Cap
    All News

    Brief: Yichang Hec Changjiang Pharmaceutical Says Insulin Aspart Injection Obtained Approval For Launch From NMPA

    Picture of Yichang Hec Changjiang Pharmaceutical Co logoYichang Hec Changjiang Pharmaceutical Co
    18/10/2022 16:05
    Oct 18 (Reuters) - YiChang HEC ChangJiang Pharmaceutical
Co Ltd  1558.HK :
    * INSULIN ASPART INJECTION HAS OBTAINED APPROVAL FOR LAUNCH
FROM
CHINA NATIONAL MEDICAL PRODUCTS ADMINISTRATION

Further company coverage:  1558.HK 
 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Yichang Hec Changjiang Pharmaceutical Co

    See all news